ISOLOGIC Innovative Radiopharmaceuticals
5450 Harvester Road
Burlington
Ontario
L7L5N5
Canada
Tel: 905-333-1789
Website: http://isologicradiopharm.ca/
About ISOLOGIC Innovative Radiopharmaceuticals
Isologic Innovative Radiopharmaceuticals (ISOLOGIC) is a nationwide radiopharmaceutical company, dedicated to nuclear medicine and the science of Radiopharmaceutical production. Our commitment to these fields extends to the communities we serve. We have nearly 100 team members focused on serving our customers and their patients. We utilize our significant experience, expertise and networks in Nuclear Pharmacy to provide our customers and patients with reliable; safe and high quality radiopharmaceutical products and services.YEAR FOUNDED:
2015
LEADERSHIP:
President: André Gagnon
VP, Global Operations: Gerard Strugala R.Ph., B.C.N.P. VP, Sales/Marketing: Christine Heneault
Associate Director: Raymond Taylor
3 articles about ISOLOGIC Innovative Radiopharmaceuticals
-
Isologic Launches Illuccix® PSMA PET Imaging Agent to Detect Prostate Cancer
3/16/2023
Isologic Innovative Radiopharmaceuticals is proud to announce that the prostate cancer imaging agent Illuccix®, Ga 68 Gozetotide Preparation Kit, also known as PSMA-11, is now available in Canada.
-
Telix and Isologic conclude manufacturing agreement for North America
6/25/2018
Telix Pharmaceuticals Limited has announced a technology transfer and manufacturing agreement with ISOLOGIC Innovative Radiopharmaceuticals
-
Isologic Release: First Diagnostic Radiotracer For Early Diagnosis Of Alzheimer's Disease Approved In Canada
2/28/2017